Inge Stijleman

Inge Stijleman

UNVERIFIED PROFILE

Are you Inge Stijleman?   Register this Author

Register author
Inge Stijleman

Inge Stijleman

Publications by authors named "Inge Stijleman"

Are you Inge Stijleman?   Register this Author

16Publications

882Reads

9Profile Views

Membrane proteins significantly restrict exosome mobility.

Biochem Biophys Res Commun 2018 07 19;501(4):1055-1059. Epub 2018 May 19.

Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2018.05.107DOI Listing
July 2018

Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.

Breast Cancer Res Treat 2016 Feb 4;155(3):483-90. Epub 2016 Feb 4.

Department of Laboratory Medicine and Pathology, University of British Columbia, 899 W 12th Ave, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3689-zDOI Listing
February 2016

Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

J Natl Cancer Inst 2015 Jul 28;107(7). Epub 2015 Apr 28.

Division of Research, Kaiser Permanente Northern California, Oakland, CA (MLK, CHK, LAH, EKW, AC, EPG, CPQJr, LHK, BJC); Huntsman Cancer Institute, University of Utah, Salt Lake City, UT (PSB, REF, IJS, CS); Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, UT (PSB, REF); Division of Epidemiology, Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT (KSM, CS); Department of Preventive Medicine, University of Southern California, Los Angeles, CA (BML).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554253PMC
July 2015

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.

Cancer Epidemiol Biomarkers Prev 2014 May 12;23(5):714-24. Epub 2014 Feb 12.

Authors' Affiliations: Division of Epidemiology, Department of Internal Medicine; Huntsman Cancer Institute, University of Utah; The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah; and Division of Research, Kaiser Permanente Northern California, Oakland, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-1023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011983PMC
May 2014

Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancer.

Clin Breast Cancer 2010 Dec;10(6):465-70

The Lineberger Comprehensive Cancer Center, and Division of Hematology/Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.n.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830095PMC
December 2010